Author: Jade Passey

Lizzie Bramall, from Nayland, was just nine when she was diagnosed with a diffuse midline glioma – one of the most aggressive paediatric high-grade gliomas.

Researchers involved in the Tessa Jowell BRAIN MATRIX study are calling for improvements to speed up the way brain tumours are diagnosed.

Toni O’Callaghan tells us about her son Jay’s glioblastoma diagnosis in 2021 and highlights the importance of funding glioblastoma research.

We are pleased to announce that we have awarded £4.5 million to three new, exciting research initiatives.

Laura Smallbone’s husband, Peter, died on 8th July 2022 after his glioblastoma recurred and there were no remaining treatment options available.

Experts at University College London, Queen Mary University of London and Great Ormond Street Hospital are to develop pioneering treatments for children diagnosed with low-grade brain tumours.

Mia Bowater-Wragg, 26, from Sheffield, received a glioblastoma diagnosis in March 2021, having first learned that she had a brain tumour in 2018.

Whole genome sequencing is the scientific term used when scientists sequence DNA.

Researchers at the University of Birmingham are paving the way to improve brain tumour treatment in a revolutionary study which collects detailed information about a person’s tumour.

Researchers at the University of Toronto have identified a biomarker that can predict how aggressive meningiomas may be in those diagnosed with this type of brain tumour.

A major UK clinical trial of an oral spray containing cannabinoids to treat the most aggressive brain tumour has opened at Leeds Teaching Hospitals NHS Trust and The Christie NHS Foundation Trust, Manchester.

Ben Johnson, 24, from Islington, was diagnosed with a brain tumour in November 2019, after suffering a seizure while at university in London.

Jerome van Leeuwen, age 42, originally from The Netherlands and now living in Fife, Scotland was first diagnosed with a pilocytic astrocytoma brain tumour when he was just two years old, it later returned in his 30s.

The Charity is supporting innovative research at the University of Sheffield, many years on from funding its very first research project there.

Karen Bucknall, 52, from Gloucestershire was diagnosed with a brain tumour in 2021 after she sought an explanation for the headaches she was experiencing throughout her chemotherapy treatment for stage 3 bowel cancer.

In a survey of 1,000 people in the UK, nearly 3 in 4 are unable to name a single symptom of a brain tumour, The Brain Tumour Charity finds.

Experts at The Everest Centre are delivering a cutting-edge program of scientific research to develop pioneering new treatments for children diagnosed with low-grade brain tumours, following major new funding from The Brain Tumour Charity.

Ramona Read was just nine-years-old when she was diagnosed with a low-grade pilocytic astrocytoma in 2021. Her mum, Vicky, shares their story ahead of their appearance on Channel 4’s The Dog House – where families are matched with dogs who hope to find their forever home.

Offering coaching to promote healthy lifestyles could help reduce severe fatigue for patients following brain tumour treatment, a clinical trial has found.

The government have signed an agreement with German pharmaceutical company BioNTech to ensure their innovative vaccine research comes to England.

Researchers have found the origin of group 3 and 4 childhood medulloblastoma, which could help develop new treatments for children diagnosed with one of the most common forms of cancerous brain tumour.

New research suggests that ulixertinib may offer one of the first targeted therapies for the most common form of brain tumour in children.

A major phase III clinical trial has found that novel treatment DCVax®-L may prolong the lives of people diagnosed with a new or recurrent glioblastoma.

We are delighted to announce the appointment of the first-ever The Brain Tumour Charity Chair of Translational Neuro-Oncology at The University of Manchester’s Cancer Research Centre (MCRC).